Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DDL
1951
Dingdong
DDL
$562M
| $2.59M | ﹤0.01% |
1,281,700
+227,077
| +22% | +$513K |
|
1952
Capital Group Municipal Income ETF
CGMU
$6.36B
| $2.59M | ﹤0.01% |
+96,919
| New | +$2.57M |
|
1953
Ollie's Bargain Outlet
OLLI
$4.44B
| $2.58M | ﹤0.01% |
19,600
-36,100
| -65% | -$4.13M |
|
1954
Mitek Systems
MITK
$754M
| $2.58M | ﹤0.01% |
260,600
-10,500
| -4% | -$94.3K |
|
1955
NB Bancorp
NBBK
$1.01B
| $2.57M | ﹤0.01% |
144,148
-58,052
| -29% | -$980K |
|
1956
SiriusPoint
SPNT
$2.75B
| $2.57M | ﹤0.01% |
126,100
-18,800
| -13% | -$346K |
|
|
PHLT
1957
DELISTED
Performant Healthcare Inc
PHLT
| $2.57M | ﹤0.01% |
641,263
-25,100
| -4% | -$71.2K |
|
1958
Capital Group Global Growth Equity ETF
CGGO
$11.4B
| $2.56M | ﹤0.01% |
+80,200
| New | +$2.37M |
|
1959
Vanguard Health Care ETF
VHT
$18.1B
| $2.56M | ﹤0.01% |
+10,300
| New | +$2.55M |
|
1960
Rackspace Technology
RXT
$1.05B
| $2.56M | ﹤0.01% |
1,998,286
-532,107
| -21% | -$693K |
|
1961
Entrada Therapeutics
TRDA
$264M
| $2.55M | ﹤0.01% |
379,500
+51,015
| +16% | +$410K |
|
1962
Solventum
SOLV
$14.8B
| $2.55M | ﹤0.01% |
33,600
+19,500
| +138% | +$1.38M |
|
1963
Peapack-Gladstone Financial
PGC
$815M
| $2.55M | ﹤0.01% |
90,113
+30,593
| +51% | +$840K |
|
1964
SLM Corp
SLM
$4.89B
| $2.54M | ﹤0.01% |
77,599
-128,401
| -62% | -$3.93M |
|
1965
Security National Financial
SNFCA
$244M
| $2.54M | ﹤0.01% |
284,291
+13,400
| +5% | +$120K |
|
1966
Amylyx Pharmaceuticals
AMLX
$2.26B
| $2.54M | ﹤0.01% |
396,200
-118,900
| -23% | -$578K |
|
|
SNT
1967
Senstar Technologies
SNT
$38M
| $2.53M | ﹤0.01% |
535,269
+500
| +0.1% | +$1.84K |
|
1968
Vanguard Russell 1000 Value ETF
VONV
$20.7B
| $2.53M | ﹤0.01% |
29,700
+24,300
| +450% | +$1.98M |
|
1969
Acco Brands
ACCO
$389M
| $2.53M | ﹤0.01% |
706,300
+80,900
| +13% | +$299K |
|
1970
Cullinan Oncology
CGEM
$1.01B
| $2.52M | ﹤0.01% |
334,525
-28,483
| -8% | -$229K |
|
1971
Hamilton Insurance Group
HG
$3.57B
| $2.52M | ﹤0.01% |
116,500
-308,116
| -73% | -$6.2M |
|
1972
Alpha Pro Tech
APT
$50.4M
| $2.51M | ﹤0.01% |
536,075
-3,484
| -0.6% | -$15.8K |
|
1973
iShares US Technology ETF
IYW
$23.6B
| $2.51M | ﹤0.01% |
+14,500
| New | +$2.2M |
|
|
CAN
1974
Canaan Creative
CAN
$127M
| $2.51M | ﹤0.01% |
4,057,001
+1,184,647
| +41% | +$833K |
|
1975
OneMain Financial
OMF
$7.2B
| $2.51M | ﹤0.01% |
44,000
-146,700
| -77% | -$7.32M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.